CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Revenue
Revenue	$ 367,877	$ 607,681
Operating expenses
Research and development	1,627,389	3,924,253
General and administrative	8,292,072	8,531,276
Impairment loss on operating right-of-use asset	3,513,999	0
Total operating expenses	13,433,460	12,455,529
Operating loss	(13,065,583)	(11,847,848)
Other income (expense)
Interest income	43	2,114
Interest expense	(2,728,101)	(47,958)
Change in fair value of convertible notes	0	(1,186,800)
Change in fair value of warrant liability	2,100,123	(75,000)
Change in fair value of derivative liability	837,146	92,110
Other income	45,945	367,738
Loss on extinguishment of debt	(15,490)	(467,073)
Total other income (expense), net	239,666	(1,314,869)
Loss before income tax expense	(12,825,917)	(13,162,717)
Income tax benefit	0	74,000
Net loss	(12,825,917)	(13,088,717)
Other comprehensive income (loss):
Foreign currency translation	64,110	(58,925)
Total comprehensive loss	$ (12,761,807)	$ (13,147,642)
Weighted average number of shares outstanding, basic (in Shares)	21,175,668	17,711,842
Basic net loss per share (in Dollars per share)	$ (0.61)	$ (0.74)
Weighted average number of shares outstanding, Diluted	21,175,668	17,711,842
Diluted net loss per share (in Dollars per share)	$ (0.61)	$ (0.74)